Study number 8524-682
Additional Screening Added
Dates
Apr 22 2024-May 13 2024
Location
Madison, Wisconsin
Age
18-65
Gender
Males and Females
Compensation
$4,430
Group
A7
Study Details
The investigational drug in this research study being developed for the potential treatment of psoriasis and for relapse-remitting multiple sclerosis. Psoriasis is a long lasting disease where the immune system becomes overactive, causing skin cells to multiply too quickly. Relapse-remitting multiple sclerosis is a long-lasting disease where the immune system attacks the nervous system, and symptoms come and go.
Fortrea Madison, WI is recruiting for:
- Healthy Males and Females of Non-Childbearing Potential, age 18-65
- Body Mass Index between 18-35
- Study involves 1 stay of 4 nights and 3 follow-up visits
- Compensation up to $4,430 may be provided for time and participation
- Refer a friend to receive up to $300 per qualified referral
Additional Details
Check-In: Apr 22
Check-Out: Apr 26
Outpatient Visits: Apr 29, May 6, May 123